Please note, preferably register only one person per company for best possible networking.
Photonics technologies have shown great promise in advancing both the diagnosis and therapy of cancer, offering highly precise, non-invasive and, in some cases, real-time solutions. Techniques such as optical coherence tomography (OCT), fluorescence imaging, and Raman spectroscopy enable early detection and detailed imaging of tumors at a cellular level. Their goal is to overcome some of the disadvantages of the traditional methods in terms of accuracy and speed of the diagnosis. Novel imaging techniques can also offer new advantages in intraoperative margin assessment in surgical oncology. For cancer therapy, photonics plays a critical role in approaches like photodynamic therapy, where light is used to activate photosensitive drugs that selectively target and destroy cancer cells. And laser sources can be used on surgical applications due to their capability to destroy tumors with minimal damage to surrounding healthy tissue. The integration of photonics with molecular imaging and targeted drug delivery systems is also enhancing the precision of cancer treatments, improving outcomes, and minimizing side effects.
In this meeting, we will bring again medical doctors from different departments to discuss with the photonics community about the actual status of the solutions they use and the remaining challenges and needs. From this discussion, integrators, manufacturing of complete systems and components manufacturers will understand the way to improve their developments to address the specific problems of the medical community. In order to support companies in this challenging process, a specific session on regulations, certifications and hospital management needs will be again organized to have new recommendations and advice from experts in these topics.